Preoperative anemia predicts poor outcome in surgically resected early-stage NSCLC patients

被引：0
|
作者：
Alexandra King
机构：
来源：
Nature Clinical Practice Oncology | 2005年 / 2卷 / 10期
关键词：
D O I：
10.1038/ncponc0281
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：489 / 489
相关论文
共 50 条
  • [41] Preoperative Low Muscle Quality Predicts Poor Outcomes After Surgery for Early-Stage Non-Small Cell Lung Cancer
    Kamigaichi, A.
    Harada, H.
    Katsumata, R.
    Hirano, K.
    Matsumoto, Y.
    Kawaguchi, K.
    Nishimura, Y.
    Miyazaki, K.
    Shibata, S.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S273 - S273
  • [42] Patient reported physical function (PF) predicts long-term survival in early-stage NSCLC surgical patients
    Pompili, C.
    Omar, S.
    Hylias, H.
    Campisi, A.
    Velikova, G.
    Valuckiene, L.
    Brunelli, A.
    ANNALS OF ONCOLOGY, 2022, 33 : S73 - S74
  • [43] AXL Is a Key Regulator of Inherent and Chemotherapy-Induced Invasion and Predicts a Poor Clinical Outcome in Early-Stage Colon Cancer
    Dunne, Philip D.
    McArt, Darragh G.
    Blayney, Jaine K.
    Kalimutho, Murugan
    Greer, Samanda
    Wang, Tingting
    Srivastava, Supriya
    Ong, Chee Wee
    Arthur, Ken
    Loughrey, Maurice
    Redmond, Keara
    Longley, Daniel B.
    Salto-Tellez, Manuel
    Johnston, Patrick G.
    Van Schaeybroeck, Sandra
    CLINICAL CANCER RESEARCH, 2014, 20 (01) : 164 - 175
  • [44] New predictors of survival for early-stage NSCLC
    Sharma, Sharan Prakash
    LANCET ONCOLOGY, 2007, 8 (04): : 288 - 288
  • [45] Gene Expression Profiling for Early-stage NSCLC
    Petrosyan, Frunze
    Daw, Hamed
    Haddad, Abdo
    Spiro, Timothy
    Sood, Ruchi
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2015, 38 (01): : 103 - 107
  • [46] The role of immunotherapy in early-stage and metastatic NSCLC
    Lieber, Attila
    Makai, Attila
    Orosz, Zsuzsanna
    Kardos, Tamas
    Isaac, Susil Joe
    Tornyi, Ilona
    Bittner, Nora
    PATHOLOGY & ONCOLOGY RESEARCH, 2024, 30
  • [47] Developments in early-stage NSCLC: advances in radiotherapy
    Verstegen, N. E.
    Lagerwaard, F. J.
    Senan, S.
    ANNALS OF ONCOLOGY, 2012, 23 : 46 - 51
  • [48] Circulating levels of PD-L1 and tumor metabolism correlate to patients outcome in surgically resected NSCLC
    Castello, Angelo
    Grizzi, Fabio
    Qehajaj, Dorina
    Toschi, Luca
    Rossi, Sabrina
    Pistillo, Daniela
    Lopci, Egesta
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [49] A Genomically Adjusted Clinicopathologic Model Predicts Recurrence in Resected Early-Stage Lung Squamous Cell Carcinoma
    Connolly, J. G.
    Tan, K. S.
    Sanchez-Vega, F.
    Jones, G. D.
    Liu, Y.
    Caso, R.
    Rocco, G.
    Park, B. J.
    Adusumilli, P. S.
    Molena, D.
    Jones, D. R.
    JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (02) : S19 - S20
  • [50] Utility of ctDNA Monitoring during Surveillance in Surgically Resected NSCLC Patients
    Ohara, S.
    Suda, K.
    Kalashnikova, E.
    Sudhaman, S.
    Cheung, S. K.
    Krainock, M.
    Feeney, J.
    Sethi, H.
    Liu, M. C.
    Soh, J.
    Tsutani, Y.
    Mitsudomi, T.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S204 - S204
12345